Skip to main content

In Q3 earnings, Boston Scientific acknowledges Covid-19 headwinds

In the company's third-quarter earnings call on Wednesday morning, Boston Scientific Corp. CEO Michael Mahoney acknowledged the business effects of the Delta surge of Covid-19, but said he was optimistic that they were temporary setbacks.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.